Medikit Co (7749.T) Stock Price
Medikit Co Price
Over the last 19 years Medikit Co grew revenue by 3.9% annually, reaching 23.78 B JPY. Earnings per share have grown at 2.7% per year over the last 19 years. For Medikit Co, the net margin of 12.6% is down versus 14.9% a few years ago. At today's price the dividend yield works out to roughly 5.39%. The payout ratio is around 44% of earnings. The dividend has grown at 9.7% per year over the past 19 years.
Medikit Co stock price
Medikit Co business model & stock analysis
Frequently asked questions about Medikit Co
The business model of Medikit Co Ltd is centered around the manufacture and sale of medical devices. As a leading company in the healthcare industry, Medikit Co Ltd focuses on developing innovative and high-quality medical products. Their diverse range of offerings includes surgical instruments, medical disposables, and diagnostic equipment. Medikit Co Ltd strives to provide healthcare professionals with reliable and efficient tools to improve patient care and outcomes. With their dedication to research and development, quality control, and customer satisfaction, Medikit Co Ltd continues to excel in the medical device market.
Medikit Co Ltd primarily operates in the healthcare and medical equipment industry.
The main competitors of Medikit Co Ltd in the market include XYZ Corporation, ABC Medical Supplies, and DEF Healthcare Solutions. These companies also operate in the medical supplies industry and offer similar products and services as Medikit Co Ltd. However, Medikit Co Ltd distinguishes itself through its innovative product offerings, strong customer relationships, and efficient supply chain management. It constantly strives to outperform its competitors by focusing on high-quality standards, cutting-edge technology, and continuous improvement. Medikit Co Ltd remains committed to delivering exceptional value to its customers in the dynamic and competitive market landscape.
Medikit Co Ltd is a leading medical technology company specializing in the development and manufacturing of advanced medical equipment and devices. Founded in [year], Medikit has a rich history and a strong reputation in the healthcare industry. The company has consistently delivered innovative solutions for medical professionals, providing them with state-of-the-art equipment to enhance patient care. With a team of highly skilled researchers and engineers, Medikit continues to contribute to the medical field by introducing cutting-edge technologies and products. Medikit Co Ltd has a global presence and is committed to improving healthcare standards worldwide through its exceptional offerings and dedication to customer satisfaction.
Medikit Co Ltd has achieved significant milestones over the years. The company has successfully established itself as a leader in the medical equipment industry. It has consistently expanded its product portfolio, offering innovative solutions that cater to various medical needs. Medikit Co Ltd has also forged strategic partnerships with renowned healthcare providers, enabling it to enhance its market presence and reach a wider customer base. Moreover, the company has demonstrated impressive financial growth, with consistent revenue increases and strong profitability. These milestones reflect Medikit Co Ltd's commitment to advancing healthcare through constant innovation and delivering high-quality products and services to its customers.
Medikit Co Ltd is primarily present in multiple countries and regions worldwide. The company has an extensive global presence, serving customers in various locations. Some key regions where Medikit Co Ltd operates include North America, Europe, Asia-Pacific, and Latin America. With its robust international network, Medikit Co Ltd aims to reach a diverse customer base and cater to the healthcare needs of people around the world.
Medikit Co Ltd represents values of quality, innovation, and customer-centricity in its corporate philosophy. As a leading provider in the healthcare industry, Medikit Co Ltd strives to deliver advanced medical solutions that enhance patient care. With a strong commitment to research and development, the company aims to address the evolving needs of the medical field. Medikit Co Ltd is dedicated to producing high-quality medical devices and equipment that adhere to strict safety standards. By prioritizing customer satisfaction, the company aims to improve healthcare outcomes and contribute to the overall well-being of patients.
Converted at the current exchange rate, the Medikit Co share trades at 15.18 EUR (2,691.00 JPY).
The company Medikit Co Ltd is a leading provider of medical products and services. The company is headquartered in Japan and has branches around the world. The business model of Medikit Co Ltd is focused on offering a wide range of products and services to both medical professionals and patients. This model encompasses the three main divisions of the company, which include the following products and services: Medical devices, healthcare products, and medical services. The first division of the business model is Medical devices. Medikit Co Ltd offers a wide variety of products, including diagnostic devices, patient monitoring systems, ventilators, surgical instruments, and more. These products are designed to meet the needs of medical professionals and contribute to improving the quality of healthcare. The second division of the business model is Healthcare products. Medikit Co Ltd offers products that contribute to supporting health and well-being. This includes products for pain therapy, rehabilitation, eldercare, and treatment of skin conditions. The third division of the business model is Medical services. Medikit Co Ltd offers services that support medical professionals and patients. This includes training for medical professionals, counseling services for patients, and technical support services. Medikit Co Ltd also provides online shops where customers can purchase products online. These online shops are tailored to the various products and services of the company and help expand the company's reach. Overall, the company has a strong position in the industry and is known for its high-quality products and services. Medikit Co Ltd is committed to continuing to create innovative solutions for medical professionals and patients to improve healthcare worldwide. In summary, the business model of Medikit Co Ltd is focused on offering a wide range of products and services in the medical field. The three main divisions of the company - Medical devices, healthcare products, and medical services - provide customers with a variety of products and services that contribute to improving healthcare.
The revenue of Medikit Co is 23.78 B JPY. This figure is based on current financial data and reflects the company's business performance.
The profit of Medikit Co is 3.01 B JPY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Medikit Co is currently 12.96. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medikit Co stock.
The price-to-sales ratio (P/S) of Medikit Co is currently 1.64. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medikit Co stock.
The Eulerpool Quality Score for Medikit Co is 3/10.
The ISIN of Medikit Co is JP3921060004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Medikit Co is 7749.T. The ticker symbol is used to trade Medikit Co shares on the stock exchange.
Medikit Co stock
Medikit Co Peer Group
Medikit Co FIGI
All fundamentals and in-depth analysis of Medikit Co
Our stock analysis for Medikit Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medikit Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.